RE: Too stringent8 Dec 2018 12:56
Saxonaxe- With the phase 3 trial being extended using 62 patients from original trial, if results due in march 2019 are significantly positive then some patients can benefit from this drug. However, the main aim is marketwide rollout which im not sure how will be possible.
Im doing research into how often drugs come to market when phase 3 results show no significance between placebo and drug. If possible